UBS Group’s Landos Biopharma, Inc. Common Stock LABP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,084
| Closed | -$87.7K | – | 9120 |
|
|
2024
Q1 | $87.7K | Buy |
4,084
+4,042
| +9,624% | +$86.8K | ﹤0.01% | 5127 |
|
|
2023
Q4 | $154 | Buy |
42
+5
| +14% | +$18 | ﹤0.01% | 7645 |
|
|
2023
Q3 | $144 | Hold |
37
| – | – | ﹤0.01% | 7649 |
|
|
2023
Q2 | $156 | Sell |
37
-591
| -94% | -$2.49K | ﹤0.01% | 7355 |
|
|
2023
Q1 | $1.87K | Buy |
628
+590
| +1,553% | +$1.76K | ﹤0.01% | 7530 |
|
|
2022
Q4 | $188 | Buy |
+38
| New | +$188 | ﹤0.01% | 9125 |
|
|
2022
Q3 | – | Sell |
-124
| Closed | -$1K | – | 10139 |
|
|
2022
Q2 | $1K | Buy |
+124
| New | +$1K | ﹤0.01% | 9066 |
|
|
2022
Q1 | – | Sell |
-381
| Closed | -$18K | – | 9949 |
|
|
2021
Q4 | $18K | Buy |
+381
| New | +$18K | ﹤0.01% | 6905 |
|
|
2021
Q2 | – | Sell |
-183
| Closed | -$18K | – | 8776 |
|
|
2021
Q1 | $18K | Buy |
+183
| New | +$18K | ﹤0.01% | 6465 |
|